Business Context and Reporting Period
Company: NEPHROS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: May 28, 2014
Principal Executive Offices: 41 Grand Avenue, River Edge, New Jersey 07661
Key Personnel: John C. Houghton (President, CEO, and Acting CFO)
Financial Metrics
This filing is a regulatory disclosure under Item 7.01 (Regulation FD) and does not contain audited financial statements or specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing serves to furnish management presentation materials (Exhibit 99.1) to the public.
Material Changes
The filing does not report specific material changes to financial performance or operations within the text of the 8-K itself. It discloses the release of management presentation materials, which may contain updates, but the 8-K text explicitly states it is not undertaking to update those materials.
Guidance, Outlook, and Risks
Management Commentary: The Company is furnishing management presentation materials as Exhibit 99.1.
Legal Disclaimer: The information in this report and Exhibit 99.1 is furnished pursuant to Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, it is not subject to the liabilities of that section, and the report is not an admission as to the materiality of any information contained therein.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Management Presentation Materials) for specific operational updates or financial projections, as the 8-K text does not contain these details.
- Note that the information provided is not "filed" under Section 18 of the Exchange Act, limiting the legal liability associated with the content.
- Verify the current status of the Acting CFO role, as John C. Houghton is listed in this capacity.